Suppr超能文献

1型人类免疫缺陷病毒Rev和Tat特异性细胞毒性T淋巴细胞频率与快速进展至艾滋病呈负相关。

Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS.

作者信息

van Baalen C A, Pontesilli O, Huisman R C, Geretti A M, Klein M R, de Wolf F, Miedema F, Gruters R A, Osterhaus A D

机构信息

Institute of Virology, Erasmus University Rotterdam, The Netherlands.

出版信息

J Gen Virol. 1997 Aug;78 ( Pt 8):1913-8. doi: 10.1099/0022-1317-78-8-1913.

Abstract

Immunological correlates of AIDS-free survival after human immunodeficiency virus type 1 (HIV-1) infection are largely unknown. Cytotoxic T lymphocyte (CTL) responses are generally believed to be a major component of protective immunity against viral infections. However, the relationship between HIV-1-specific CTL responses and disease progression rate is presently unclear. Here we show in twelve HIV-1-infected individuals that detection of Rev-specific CTL precursors (CTLp) early in the asymptomatic stage, as well as detection of Rev- and Tat-specific CTLp later during follow-up, inversely correlate with rapid disease progression. No such correlation was found for detection of CTLp against Gag, RT or Nef. Further studies are required to determine whether a protective mechanism is indeed the basis of the observed correlation. The data presented are in agreement with the hypothesis that CTL against proteins that are important for early viral transcription and translation are of particular importance in protection from rapid disease progression.

摘要

1型人类免疫缺陷病毒(HIV-1)感染后无艾滋病生存的免疫相关因素很大程度上尚不清楚。细胞毒性T淋巴细胞(CTL)反应通常被认为是针对病毒感染的保护性免疫的主要组成部分。然而,目前HIV-1特异性CTL反应与疾病进展速率之间的关系尚不清楚。在此,我们在12名HIV-1感染个体中发现,在无症状期早期检测到Rev特异性CTL前体(CTLp),以及在随访后期检测到Rev和Tat特异性CTLp,与疾病快速进展呈负相关。针对Gag、RT或Nef的CTLp检测未发现此类相关性。需要进一步研究以确定保护机制是否确实是观察到的相关性的基础。所呈现的数据与以下假设一致,即针对对早期病毒转录和翻译重要的蛋白质的CTL在预防疾病快速进展中特别重要。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验